Development of a novel diagnosis marker for kidney diseases by metabolome analysis
Project/Area Number |
15K21364
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Kidney internal medicine
General physiology
|
Research Institution | Keio University |
Principal Investigator |
HIRAYAMA Akiyoshi 慶應義塾大学, 政策・メディア研究科(藤沢), 特任講師 (00572405)
|
Research Collaborator |
MARUYAMA Shoichi
AKIYAMA Shinichi
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2017: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 腎疾患 / マーカー / CE-MS / 尿 / 血漿 / ネフローゼ / メタボロミクス / バイオマーカー |
Outline of Final Research Achievements |
In this study, a comprehensive analysis of urine and plasma metabolites from nephrotic disease patients was conducted by capillary electrophoresis-mass spectrometry (CE-MS) in order to discover biomarkers specific to the type of disease. As a result, it was possible to create a model to distinguish from seven types of nephrotic diseases by combining two to five types of metabolites. With respect to unknown peaks, it was possible to perform a fractionation operation using LC-MS to identify new biomarker candidates.
|
Report
(4 results)
Research Products
(13 results)
-
-
-
[Journal Article] Comparative analysis of cerebrospinal fluid metabolites in Alzheimer’s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort.2018
Author(s)
1)Nagata Y, Hirayama A, Ikeda S, Shirahata A, Shoji F, Maruyama M, Kayano M, Bundo M, Hattori K, Yoshida S, Goto Y, Urakami K, Soga T, Ozaki K and Niida S.
-
Journal Title
Biomarker Research
Volume: 6
Issue: 1
Pages: 1-11
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Thymidine Catabolism as a Metabolic Strategy for Cancer Survival2017
Author(s)
Tabata S, Yamamoto M, Goto H, Hirayama A, Ohishi M, Kuramoto T, Mitsuhashi A, Ikeda R, Haraguchi M, Kawahara K, Shinsato Y, Minami K, Saijo A, Hanibuchi M, Nishioka Y, Sone S, Esumi H, Tomita M, Soga T, Furukawa T, Akiyama SI
-
Journal Title
Cell Rep
Volume: 19
Issue: 7
Pages: 1313-1321
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC2017
Author(s)
Satoh K, Yachida S, Sugimoto M, Oshima M, Nakagawa T, Akamoto S, Tabata S, Saitoh K, Kato K, Sato S, Igarashi K, Aizawa Y, Kajino-Sakamoto R, Kojima Y, Fujishita T, Enomoto A, Hirayama A, Ishikawa T, Taketo MM, Kushida Y, Haba R, Okano K, Tomita M, Suzuki Y, Fukuda S, Aoki M, Soga T.
-
Journal Title
Proc Natl Acad Sci U S A
Volume: 114
Issue: 37
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Efficacy of Indigo naturalis in a Multicenter Randomized Controlled Trial of Patients with Ulcerative Colitis2017
Author(s)
.Naganuma M, Sugimoto S, Mitsuyama K, Kobayashi T, Yoshimura N, Ohi H, Tanaka S, Andoh A, Ohmiya N, Saigusa K, Yamamoto T, Morohoshi Y, Ichikawa H, Matsuoka K, Hisamatsu T, Watanabe K, Mizuno S, Suda W, Hattori M, Fukuda S, Hirayama A, Abe T, Watanabe M, Hibi T, Suzuki Y, Kanai T
-
Journal Title
Gastroenterology
Volume: 4
Issue: 4
Pages: 935-947
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-